Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0014 Transporter Info | ||||
| Gene Name | ABCB11 | ||||
| Transporter Name | Bile salt export pump | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Fluvastatin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 446155 | ||||
| Docking Score | -12.104 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H26FNO4 | ||||
| Molecular Weight | 411.5 | ||||
| Canonical SMILES |
CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F
|
||||
| InChI |
InChI=1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19-/m1/s1
|
||||
| InChIKey | FJLGEFLZQAZZCD-MCBHFWOFSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.5 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Troglitazone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5591 | ||||
| Docking Score | -12.08 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H27NO5S | ||||
| Molecular Weight | 441.5 | ||||
| Canonical SMILES |
CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
|
||||
| InChI |
InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)
|
||||
| InChIKey | GXPHKUHSUJUWKP-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.1 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Budesonide Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5281004 | ||||
| Docking Score | -11.838 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H34O6 | ||||
| Molecular Weight | 430.5 | ||||
| Canonical SMILES |
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
|
||||
| InChI |
InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
|
||||
| InChIKey | VOVIALXJUBGFJZ-KWVAZRHASA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.5 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.